Immunohistochemistry
| Name | Preis | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-Human/Mouse/Rat Activin A βA Subunit - 100 µg | Anmelden | Anti-Human/Mouse/Rat Activin A βA Subunit - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human/Mouse/Rat ARC - 25 µg | Anmelden | Anti-Human/Mouse/Rat ARC - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human/Mouse/Rat ARC - 100 µg | Anmelden | Anti-Human/Mouse/Rat ARC - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse Angiopoietin-3 - 25 µg | Anmelden | Anti-Mouse Angiopoietin-3 - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse Angiopoietin-3 - 100 µg | Anmelden | Anti-Mouse Angiopoietin-3 - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Mouse Artemin-Biotin - 50 µg | Anmelden | Anti-Mouse Artemin-Biotin - 50 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Astrocytes - Purified - 0.125 mg | Anmelden | Anti-Astrocytes - Purified - 0.125 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human β-Amyloid Precursor Protein (AβNT) (APP) - 0.1 mg | Anmelden | Anti-Human β-Amyloid Precursor Protein (AβNT) (APP) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human β-Amyloid Precursor Protein (CT) (APP) - 0.1 mg | Anmelden | Anti-Human β-Amyloid Precursor Protein (CT) (APP) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Acinus (C--Terminus 1) - 0.1 mg | Anmelden | Anti-Human Acinus (C--Terminus 1) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Acinus (C-Terminus 2) - 0.1 mg | Anmelden | Anti-Human Acinus (C-Terminus 2) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Acinus (Intermediate Domain) - 0.1 mg | Anmelden | Anti-Human Acinus (Intermediate Domain) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Act1 (CT) - 0.1 mg | Anmelden | Anti-Human Act1 (CT) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Act1 (NT) - 0.1 mg | Anmelden | Anti-Human Act1 (NT) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Amino-terminal Enhancer of Split (CT) (AES) - 0.1 mg | Anmelden | Anti-Human Amino-terminal Enhancer of Split (CT) (AES) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Apoptosis Antagonizing Transcription Factor (AATF) - 0.1 mg | Anmelden | Anti-Human Apoptosis Antagonizing Transcription Factor (AATF) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Apoptosis Inducing Factor (CT) (AIF) - 0.1 mg | Anmelden | Anti-Human Apoptosis Inducing Factor (CT) (AIF) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Apoptosis Inducing Factor (NT) (AIF) - 0.1 mg | Anmelden | Anti-Human Apoptosis Inducing Factor (NT) (AIF) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Apoptosis Related Protein (NT) (ARTS) - 0.1 mg | Anmelden | Anti-Human Apoptosis Related Protein (NT) (ARTS) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Apoptosis Repressor with CARD Domain (CT) (ARC) - 0.1 mg | Anmelden | Anti-Human Apoptosis Repressor with CARD Domain (CT) (ARC) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human APRIL (Extracellular Domain-2) - 0.1 mg | Anmelden | Anti-Human APRIL (Extracellular Domain-2) - 0.1 mg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Artemin - 25 µg | Anmelden | Anti-Human Artemin - 25 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Artemin - 100 µg | Anmelden | Anti-Human Artemin - 100 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human Amino-terminal Enhancer of Split (CT) (AES) - 20 µg | Anmelden | Anti-Human Amino-terminal Enhancer of Split (CT) (AES) - 20 µg | ||||||||||||||||
|
||||||||||||||||||
| Anti-Human APRIL (Extracellular Domain-2) - 20 µg | Anmelden | Anti-Human APRIL (Extracellular Domain-2) - 20 µg | ||||||||||||||||
|
||||||||||||||||||


